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Abstract
Background: Human cytomegalovirus (HCMV) encodes microRNAs (miRNAs) that function as post-transcriptional regulators
of gene expression during lytic infection in permissive cells. Some miRNAs have been shown to suppress virus replication,
which could help HCMV to establish or maintain latent infection. However, HCMV miRNA expression has not been
comprehensively examined and compared using cell culture systems representing permissive (lytic) and semi-permissive vs.
non-permissive (latent-like) infection.
Methods: Viral miRNAs levels and expression kinetics during HCMV infection were determined by miRNA-specific stem-loop
RT-PCR. HCMV infected THP-1 (non-permissive), differentiated THP-1 (d-THP-1, semi-permissive) and human embryo lung
fibroblasts (HELs, fully-permissive) were examined. The impact of selected miRNAs on HCMV infection (gene expression,
genome replication and virus release) was determined by Western blotting, RT-PCR, qPCR, and plaque assay.
Results: Abundant expression of 15 HCMV miRNAs was observed during lytic infection in HELs; highest peak inductions (11-
to 1502-fold) occurred at 48 hpi. In d-THP-1s, fourteen mRNAs were detected with moderate induction (3- to 288-fold), but
kinetics of expression was generally delayed for 24 h relative to HELs. In contrast, only three miRNAs were induced to low
levels (3- to 4-fold) during quiescent infection in THP-1s. Interestingly, miR-UL70-3p was poorly induced in HEL (1.5-fold),
moderately in THP-1s (4-fold), and strongly (58-fold) in d-THP-1s, suggesting a potentially specific role for miR-UL70-3p in
THP-1s and d-THP-1s. MiR-US33, -UL22A and -UL70 were further evaluated for their impact on HCMV replication in HELs.
Ectopic expression of miR-UL22A and miR-UL70 did not affect HCMV replication in HELs, whereas miR-US33 inhibited HCMV
replication and reduced levels of HCMV US29 mRNA, confirming that US29 is a target of miR-US33.
Conclusions: Viral miRNA expression kinetics differs between permissive, semi-permissive and quiescent infections, and
miR-US33 down-regulates HCMV replication. These results suggest that miR-US33 may function to impair entry into lytic
replication and hence promote establishment of latency.
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Introduction
Human cytomegalovirus (HCMV) is a ubiquitous pathogen
infecting 50% to 90% of the population worldwide, with an
extremely high prevalence (.90%) in China. HCMV infection is
not believed to be deleterious to immunocompetent individuals.
However, it can cause serious, often life-threatening complications
in immunocompromised individuals, including solid organ and cell
transplant recipients, AIDS patients, and patients suffering from
late stage cancers (reviewed by Mercorelli [1]). Above all,
congenital HCMV infection of immunologically immature fetuses
is the most common viral cause of birth defects, affecting 0.1–0.3%
of newborns [2,3].
HCMV establishes life-long latency following primary infection.
Latency is a shared feature of Herpesviridae and for viruses in the
alpha- and gamma-herpesvirus subfamilies is associated with
expression of viral microRNAs (miRNA) (reviewed in [4]).
MiRNAs are a class of non-coding RNAs of about 20–22
nucleotides (nt) in length. More than 10,000 miRNAs have been
identified in a variety of organisms [5]. They participate in
developmental processes (hematopoiesis, organogenesis, cell pro-
liferation, differentiation and apoptosis), regulation of virus
infection and anti-viral immune responses [4].
Viral miRNAs play important roles in regulation of virus
infection by interacting with virus genes or regulating host genes to
create a favorable cellular environment for virus replication [6].
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Viral miRNAs were first identified in Epstein-Barr virus (EBV), a
gamma-subfamily member of Herpesviridae [7]. To date over 230
viral miRNAs have been identified; most of which are encoded by
herpesviruses. EBV encodes 25, Kaposi’s sarcoma-associated
herpesvirus (KSHV) encodes 12, murine cytomegalovirus
(MCMV) encodes 18, and HCMV expresses 16 miRNAs [4,8].
During latency the lytic viral replication cycle is repressed such
that viral DNA is present but no infectious virus is produced.
Upon certain external stimulations latent virus can be reactivated
to lytic replication. The molecular mechanisms that govern
establishment, maintenance, and reactivation from latency are
poorly understood. MiR-BART2 encoded by EBV inhibits the
lytic viral gene BALF5 and thus may play an important role in
maintenance of EBV latency [9]. Similarly, KSHV-encoded miR-
9 inhibits expression of the viral protein RTA and miR-K1 targets
IkBa to activate the NF-kB pathway, which in turn prevents lytic
infection of KSHV and promotes latency [10,11]. Viral miRNAs
also regulate host immune responses and mediate viral immune
evasion. For example, HCMV miR-UL112-1, EBV miR-BART2-
5p, and KSHV miR-K12-7 help to protect infected cells from
natural killer (NK) cell recognition by suppressing expression of
major histocompatibility complex class I-related chain B (MICB),
which mediates NK cell recognition via NKG2D [12,13].
The functions of some HCMV miRNAs have been character-
ized. MiR-UL112-1 targets UL123 (IE1), UL112/113 and
UL120/121, which are important for HCMV lytic infection
[14]. HCMV miR-US25-1 and miR-US25-2 indirectly regulate
viral replication, and miR-US25-1 inhibits expression of cytokines
and cellular factors involved in signaling and cell cycle [15].
In the present work expression and kinetics of 16 mature
HCMV miRNAs were examined in different cell culture systems
representing permissive, semi-permissive, and quiescent/latent-like
infections. THP-1 acute monocytic leukemia cells [16] were used
to model quiescent infection. Infection of these cells results in
maintenance of the HCMV genome without progression to the
lytic replication pathway [17–23]. Viral gene expression is largely
repressed during quiescent infection, but expression of lytic genes
and viral DNA amplification can be induced by phorbol-ester
treatment [18,19,24], which drives differentiation of THP-1 cells
into macrophages [25]. THP-1 cells differentiated prior to
infection (d-THP-1) were used as a model of semi-permissive
infection as 10 - 40% of these cells become productively infected
[20,23,26]. Human embryonic lung fibroblasts (HELs) were used
to model highly efficient fully permissive lytic replication. Most of
the HCMV miRNAs were abundantly expressed during permis-
sive and semi-permissive replication and repressed during quies-
cent infection. One miRNA was selectively induced in THP-1/
d-THP-1 cells and not in HELs. HCMV miRNAs were grouped
in three groups based on kinetic patterns of expression in HELs.
Three previously uncharacterized miRNAs (miR-UL22A, miR-
UL70 and miR-US33), each representing one group, were further
examined to determine their impact on viral replication. At low
multiplicity of infection (MOI) miR-US33 down regulated viral
gene expression, inhibited viral genome replication, and reduced
infectious virus yield. These results suggest that miR-US33 is a
player in regulating HCMV lytic infection.
Materials and Methods
Ethics statement
The Wuhan Institute of Virology Institutional Review Board
approved the isolation of primary human embryonic lung
fibroblasts from postmortem fetal embryo tissue and waived the
need for consent. The original source of the postmortem fetal
embryo tissue was the Zhongnan Hospital.
Cells and cell culture
Primary HELs (maintained in our laboratory, [27]), THP-1 cells
(ATCC- TIB202), and embryonic kidney 293T/17 cells (ATCC-
CRL11268) were cultured in Eagle’s minimal essential medium
(MEM, Gibco BRL), RPMI 1640 medium (Gibco BRL) and
Dulbecco’s modified Eagle’s medium (DMEM, Gibco BRL),
respectively. All media were supplemented with 10% fetal bovine
serum, 100 units/ml penicillin, 100 mg/ml streptomycin and
2 mM L-glutamine (Gibco BRL). THP-1 cells were differentiated
(d-THP-1) by treatment with phorbol 12-myristate 13-acetate
(PMA, 12.5 ng/ml) and hydrocortisone (1.8 mg/ml) (Sigma) for
24 hour (h) prior to HCMV infection as described [26]. Cells were
maintained at 37uC in a humidified atmosphere containing 5%
CO2.
Plasmid construction and lentiviruses production
Lentivirus expression system, including plasmids pCDH-CMV-
MCS-EF1-copGFP and pML-delta8.9 and pVSV-G (System
Biosciences, CA, USA), was used to ectopically express HCMV-
encoded miRNAs. Sequences of HCMV-encoded pre-miRNAs
were obtained from miRBase/Release 20 (http://www.mirbase.
org/) and PCR-amplified using HCMV DNA (strain Towne) as
the template. Primers and product sizes are listed in Table 1. PCR
products were cloned into EcoRI/BamHI-digested pCDH-CMV-
MCS-EF1-copGFP to make plasmids pCDH-miR-UL22A,
pCDH-miR-UL70 and pCDH-miR-US33 containing miR-
UL22A, miR-UL70, miR-US33 inserts, respectively. Lentiviruses
were generated by co-transfecting 15 mg of pCDH-miR-UL22A,
pCDH-miR-UL70, or pCDH-miR-US33 with 6 mg of pVSV-G
(encodes vesicular stomatitis virus G protein) and 12 mg pML-
delta8.9 (encodes HIV structural proteins) into 293T cells using
calcium phosphate as described [28]. At 48 h post transfection the
supernatants containing lentiviruses were collected, clarified of cell
debris by centrifugation (1500 rpm, 10 min62), filtered through a
0.45 mm membranes, and stored at 280uC. Lentivirus stocks were
titered by counting copGFP-positive cells as described [29].
Virus and infection
HCMV Towne strain (ATCC-VR977) was propagated and
titered as described previously [30]. For kinetic studies of miRNA
expression, HELs were infected with HCMV at a multiplicity of
infection (MOI) of 5. After 3 h the culture medium was replaced
with fresh medium. THP-1 and d-THP-1 cells were infected in
parallel at an MOI of 10.
Table 1. Primers used for cloning HCMV pre-miRNAs.
Primer
names Primers sequence
Product
size
miR-UL22AF CCGGAATTCTCTTCCCATAGCCTGTCTAA
miR-UL22AR CGCGGATCCGCCGCAGCATCCCGCATA 100 bp
miR-UL70F CGCGGATCCGAGAGCACGGGCGTGCGGAA
miR-UL70R CCGGAATTCGCCGTGAACAACGAAACGCT 140 bp
miR-US33F CGCGGATCCGACGTAGGAAAGGATCATGT
miR-US33R CCGGAATTCTAAGACGTGTCATTGTTGTC 200 bp
doi:10.1371/journal.pone.0088531.t001
HCMV miRNA Expression
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HELs were transduced with lentiviruses lacking an insert (vector
control) or expressing HCMV miRNAs at an MOI of 10. After
confirmation of miRNA expression by RT-PCR at 48 h after
transduction (described below), transduced HELs were infected
with HCMV at MOIs of 0.01, 0.1, 1, or 5. Cells were harvested for
RNA, DNA, and Western blotting studies at 24, 48 and 72 h post
infection (hpi) and supernatants were collected and titered for
infectious HCMV at 96 and 144 hpi.
RT-PCR
HCMV-encoded miRNAs were detected by stem-loop RT-
PCR. Total RNA was isolated from HCMV-infected cells using
Trizol Reagent (TaKaRa) and DNA was removed using
Recombinant DNase I (TaKaRa). One mg of each RNA sample
was reverse transcribed with RevertAidTM H Minus First Strand
cDNA Synthesis Kit (Fermentas) using miRNA-specific stem-loop
RT primers (Table 2) as described previously [31-33]. RT reaction
products were quantified by quantitative PCR (qPCR) using All-
in-OneTM qPCR Mix (GeneCopoeia) with a CFX ConnectTM
Real-Time System (BIO-RAD). 20 ml PCR reactions contained
2 ml RT reaction product, 10 ml 26qPCR Mix, and 250 nM
forward and reverse primers (Table 2). Reactions were denatured
at 95uC for 3 min, followed by 40 two-step cycles of 95uC for 10 s
and 60uC for 30 s. Expression of HCMV-US29 was assessed by
qRT-PCR with specific F primer (59-CGACGAGACAACAAT-
GAC39) and R primer (59-AATTGACGGTCCACTGAG39) as
described above. Expression levels of 5sRNA were measured to
confirm consistency of RNA extraction and amplification between
samples.
qPCR
DNA was extracted from cell pellets using TIANamp Genomic
DNA Kit (TIANGEN) and adjusted to 10 ng/ml. HCMV DNA
was detected using primers from the IE1 gene locus (F primer
59AACTCAGCCTTCCCTAAGACCA39, R primer 59 CAG-
CACCCGACAGAACTCAC 39). Amplification of GAPDH
sequences using primers F 59 GTTTACATGTTCCAATATGA
39 and R 59 TCCTGGAAGATGGTGATGGG served as an
internal reference. 20 ml qPCR reactions contained 2 ml (20 ng)
DNA, 50 nM forward and reverse primers, and 10 ml 26
iTaqTMSYBR Green Supermix (BIO-RAD). Reactions were
denatured at 95uC for 5 min, followed by 40 cycles of 95uC for
10 s and 54uC for 20 s using a CFX ConnectTM Real-Time Sysem
(BIO-RAD).
Western blotting
Cell lysates were prepared as described previously [30]. Protein
concentrations were quantified using the BCA assay (Beyotime)
and equal amounts of protein (50 mg) were separated by SDS-
PAGE using 8% polyacrylamide gels. Proteins were transferred to
ImmobilonH-P membranes (IPVH00010, Millipore). Detection of
proteins was described previously [30]. Primary antibodies
included mouse monoclonals Ch16.0 (anti-HCMV IE1/2;
Virusys), Ch13.0 (anti-HCMV UL44; Virusys), 27–156 (anti-
HCMV glycoprotein B, a gift from William Britt, University of
Alabama), and C4 (anti-actin; Santa Cruz Biotechnology). The
secondary antibody was horseradish peroxidase-conjugated sheep
anti-mouse IgG (GE healthcare).
Luciferase assay
A luciferase reporter assay was constructed to assess miR-US33
regulation of US29 expression. A 500-bp region of US29 sequence
was PCR amplified using primers 59CGGGGTACCGCTCTA-
CAGTGGGTGGTGGT39 and 59CCGCTCGAGAAGCGTTG-
CCGTAGCTGGCG39 and cloned into a modified pGL3 plasmid,
pGL3cM, that contains a firefly luciferase reporter gene (Promega,
Madison, USA) to make plasmid pGL3-Luc-US29. b-galactosidase
(b-gal) expression from plasmid pCMV-SPORT-b-gal (kind gift from
J Melendez at the College of Nanoscale Sciences and Engineering,
SUNY, Albany, USA) was used as a transfection control. pGL3-Luc-
US29 and pCMV SPORT-b-gal were cotransfected into 293T cells
along with either pCDH-miR-US33 or the pCDH-copGFP empty
vector control using calcium phosphate as described [34]. Cells were
harvested at 48 h post transfection, luciferase activities were
measured using pGL3 Luciferase Reporter Vectors kit (Promega),
and b-gal activities were measured using b-Galactosidase Enzyme
Assay System with Reporter Lysis Buffer kit (Promega). Signals were
quantitated using a Modulus TM II microplate multimode reader.
Statistical analyses
All reactions were run in triplicate for each experiment. Three
independent experiments were performed. Data were analyzed by
One-way ANOVA. Results reported are means 6 standard
deviations (SD). Differences were considered to be significant
when P values were less than 0.05.
Results
HCMV miRNA expression during permissive replication in
HELs
Twenty three mature miRNAs encoded by HCMV have been
reported, however, only 16 of the 23 mature miRNAs are in the
database of miRBase/Release 20 [35]. To evaluate the expression
kinetics of HCMV-encoded miRNAs during productive infection
in fully-permissive cells, HELs were infected with HCMV (Towne)
at an MOI of 5 and RNA was isolated at different time points post-
infection. Levels of the 16 HCMV miRNAs described in
miRBase/Release 20 were measured by stem-loop RT followed
by qPCR. Relative expression levels were expressed as fold
changes relative to levels at 3 hpi. All 16 miRNAs increased as
early as 6 hpi and reached maximum levels at 48 hpi followed by
either steep or gradual declines at 72 hpi (Fig. 1).
Based on patterns of expression, HCMV miRNAs could be
classified into three groups. Group 1 miRNAs (11 miRNAs: miR-
UL36-5/3p, -UL112, -US4, -US5-1, -US5-2, -US25-1-5/3p,
-US25-2-5/3p and -US33-3p) increased gradually and reached
high expression levels (.30-fold induction) at 48 hpi, then
declined somewhat but remained high (.8-fold) at 72 hpi, when
progeny virus production is vigorous (Fig. 1A). Group 2 miRNAs
(4 miRNAs: miR-UL22A-5/3p, -UL70-5p and -US33-5p) in-
creased more slowly to reach moderate levels (,10-fold) before
48 hpi, then abruptly increased to 10- to 30-fold levels at 48 hpi,
and decreased steeply to low levels at 72 hpi (Fig. 1B). The one
miRNA in group 3 (miR-UL70-3p) showed no induction prior to
48 hpi, peaked at a low level (1.5-fold) at 48 hpi, and thereafter
declined dramatically (Fig. 1C).
These results suggest that group 1 miRNAs may have functions
that are important early in the HCMV replicative cycle, as
significant levels are attained prior to the onset of DNA synthesis
at ,24 hpi. Group 2 and 3 miRNAs may have later functions as
their levels do not rise until 48 hpi, when viral DNA synthesis is
underway and progeny virus assembly has begun.
HCMV miRNAs were repressed during quiescent infection
in THP-1 cells
To examine HCMV miRNA expression during quiescent
infection, undifferentiated THP-1 monocytes were infected at an
HCMV miRNA Expression
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MOI of 10 and expression levels of the 16 HCMV miRNAs were
determined at different hpi. Thirteen of the 16 miRNAs exhibited
either little change or declined significantly after infection. This is
in stark contrast to HELs in which these miRNAs increased 11- to
1502-fold. Three miRNAs (miR-UL70-3p, -UL112 and -US5-1)
exhibited slight (3 to 4-fold) inductions, but only at 72 hpi (Fig. S1).
The relative inductions of these three miRNAs in THP-1s differed
significantly from those in HELs (i.e., 3-fold vs. 33-fold for miR-
UL112, 4-fold vs. 1.5-fold for miR-UL70-3p, and 3-fold vs. 209-
fold for miR-US5-1). Differences between the two cell types in
kinetics and induction levels for four representative miRNAs are
illustrated in Fig. 2. In HELs miR-UL112 and miR-US33-3p
(group 1) were rapidly induced, while miR-UL22A-5p (group 2)
was delayed. However, by 48 hpi all three reached high peak
levels (32-, 101-, and 19-fold, respectively). In contrast, all three
miRNAs declined in THP-1 cells after 3 hpi and either remained
very low (miR-UL22A-5p) or increased slightly (mi-UL112 and -
US33-3p) at 72 hpi. Remarkably, kinetics of miR-UL70-3p were
quite similar in the two cell types until 72 hpi when there was a 4-
fold increase in THP-1 cells and a dramatic decline in HELs
(Fig. 2).
These results suggest that, similar to lytic gene transcription,
most HCMV miRNAs are repressed in THP-1 cells. MiR-UL70-
3p appears to be uniquely expressed in THP-1s but its late time of
induction would seem to preclude a role in establishing a quiescent
state.
Table 2. Primers used for quantitation of viral miRNA by stem-loop RT-PCR.
Primer names Primer sequences size
RT (miRNAs)
5S rRNA CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGAAAGCCTA
UL22A-5p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTCTCACGG
UL22A-3p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGCTACAAAC
UL36-5p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTCTTTCCA
UL36-3p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGGCACGTTG
UL70-5p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTCTGGACG
UL70-3p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGCCGCGCGC
UL112 CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGAGCCTGGA
US4 CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGATCCCCCT
US5-1 CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGACGCTCTC
US5-2 CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGGACATCGT
US25-1-5p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGGGTCCGAG
US25-1-3p CTCAACTGGTGTCGTGGAGTCGGAATTCAGTTGAGGAGAACCG
US25-2-5p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTCATCCAC
US25-2-3p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGCCGCGGGA
US33-5p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGCGCCCACG
US33-3p CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTGGATGTG
PCR (miRNAs)
5S rRNA GTCTACGGCCATACCACCCTGAAC 157 bp
UL22A-5p TAACTAGCCTTCCCG 56 bp
UL22A-3p TCACCAGAATGCTAGT 58 bp
UL36-5p TCGTTGAAGACACCTG 58 bp
UL36-3p TTTCCAGGTGTTTTCA 58 bp
UL70-5p TGCGTCTCGGCCTCGT 57 bp
UL70-3p GGGGATGGGCTGGCGC 56 bp
UL112 AAGTGACGGTGAGATCCA 58 bp
US4 CGACATGGACGTGCAG 58 bp
US5-1 TGACAAGCCTGACGAG 57 bp
US5-2 TTATGATAGGTGTGAC 58 bp
US25-1-5p AACCGCTCAGTGGCTC 57 bp
US25-1-3p TCCGAACGCTAGGTCG 58 bp
US25-2-5p AGCGGTCTGTTCAGGT 58 bp
US25-2-3p ATCCACTTGGAGAGCT 59 bp
US33-5p GATTGTGCCCGGACCGTG 58 bp
US33-3p TCACGGTCCGAGCAC 56 bp
Universal R CTCAACTGGTGTCGTGGA
doi:10.1371/journal.pone.0088531.t002
HCMV miRNA Expression
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Figure 1. Expression kinetics of HCMVmiRNAs during lytic replication in HELs. HELs were infected with HCMV strain Towne at an MOI of 5
and intracellular HCMV miRNAs were quantitated by stem-loop RT-PCR at the indicated times post infection. Results indicate fold-changes relative to
levels measured at 3 hpi. HCMV miRNAs were assigned to group 1 (A), group 2 (B) or group 3 (C) based on kinetic patterns of expression (see text for
details).
doi:10.1371/journal.pone.0088531.g001
HCMV miRNA Expression
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Differentiation resulted in increased induction of many
but not all miRNAs during semi-permissive infection in d-
THP-1 cells
To determine how differentiation to a semi-permissive state
alters the expression of HCMV miRNAs, THP-1 cells were
differentiated by culture for 24 h in the presence of PMA and
hydrocortisone prior to HCMV infection. The resulting d-THP-1
cells were infected at an MOI of 10 and expression levels of the 16
HCMV miRNAs were determined at different hpi. Differentiation
profoundly affected patterns and levels of miRNA expression in d-
THP-1s relative to THP-1s. Thirteen of the 15 miRNAs (except
miR-UL70-3p) that were strongly induced during HEL infection
(but not induced in THP-1 cells) exhibited induction increases as a
result of differentiation (Fig. S2). Of these, three were increased
over THP-1 levels but inductions remained relatively low (,4-
fold; miR-US25-2-5p, -UL22A-5p, and -UL22A-3p), four were
significantly induced (.7-fold) but not to levels seen in HELs
(miR-UL36-5p, -US5-1, -US25-2-3p, -US33-3p), four increased to
levels very similar to those in HELs (miR-US4, -US25-1-5p,
-US25-1-3p, and -US70-5p), and two reached levels significantly
higher than those in HELs (miR-UL112 and -US33-5p) (Table
S1). In general miRNA expression was delayed approximately
24 h in d-THP-1s vs. HELs. One exception was miR-US33-5p,
which was induced to higher levels 24 h earlier in d-THP-1 cells
vs. HELs. The other exception was miR-UL70-3p, which was
basically not induced in HELs, but dramatically induced to higher
levels from 24 hpi on and maintained higher (Fig 3, Fig S2 and
Table S1).
Differences between THP-1 and d-THP-1 cells in kinetics and
induction levels for four representative miRNAs are illustrated in
Fig. 3. MiR-UL112 and miR-UL70-3p were essentially uninduced
in THP-1s but were induced dramatically in d-THP-1s from 24
hpi on. In contrast, miR-UL22A-5p was uninduced in both cell
types while miR-US33-3p was moderately induced in d-THP-1s at
72 hpi.
These results suggest that a subset of HCMV miRNAs are
significantly expressed during lytic infection independent of cell
type, while high expression levels of other miRNAs are unique to
HELs or d-THP-1s. This suggests that differences in HCMV
miRNA expression between THP-1, d-THP-1, and HEL cells
cannot be simply explained by different percentages of cells
entering quiescent vs. lytic infection in each cell type. The
exclusive induction of miR-UL70-3p in d-THP-1s indicates that
miR-UL70-3p induction may be THP-1 cell specific and cell
differentiation associated.
HCMV miR-US33 inhibited HCMV replication
Three previously uncharacterized HCMV miRNAs, miR-
US33, miR-UL22A and miR-UL70, were selected for further
study based on changes in induction upon differentiation. HELs
were transduced with lentiviruses expressing pre-miR-US33, pre-
miR-UL22A, pre-miR-UL70, or empty vector control. Each
miRNA was measured by stem-loop RT/qPCR at 48 h after
transduction. The signal from miR-US33-transduced cells was
254-fold above that of empty vector-transduced cells, and those for
miR-UL22A and miR-UL70 were 151-fold and 17-fold, respec-
tively. However, transduced levels of miR-US33, miR-UL22A and
miR-UL70 were 4375-, 106300- and 1267-fold lower, respectively,
than levels induced 48 h post HCMV infection of untransduced
HELs (Fig. 4A). Hence, ectopical expression of these miRNAs
through lentivral transduction may only have been significant
prior to 48 h post HCMV infection as by this time HCMV-
Figure 2. Comparison of miRNA expression in HCMV infected HEL and THP-1 cells. Expression kinetics for four HCMV miRNAs representing
the three expression pattern groups are shown side-by-side to compare expression patterns in HELs vs. THP-1s (data are from experiments described
in Figs. 1 and S1). The compared representatives of group 1 (miR-112 and miR-70-3p), group 2 (miR-22A-5p), and group 3 (miR-US33-3p) are shown.
Note that HELs and THP-1 cells were infected with HCMV strain Towne at MOIs of 5 and 10, respectively. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0088531.g002
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encoded miRNA expression far exceeded lentiviral-mediated
expression.
Transduced HELs were then infected with HCMV at MOIs of
0.01, 0.1, 1 or 5. Expression of representative immediate early
(IE1/IE2), early (UL44), and late (glycoprotein B, gB) viral
proteins was assessed by Western blotting, viral DNA replication
was measured by qPCR, and virus yield was determined by
titering infectious virus released into culture supernatants.
Transduction of miR-UL22A-5p and miR-UL70-5p had no
apparent effects on HCMV infection at all the MOIs tested, and
miR-US33 had no effects at MOIs of 0.1, 1 or 5 (Fig. 4B, data not
shown). However, at MOI= 0.01 levels of IE1/IE2, UL44, and gB
were significantly reduced in miR-US33-transduced cells (Fig. 4B).
Viral DNA replication was also reduced from 0.6 to 0.2 copies/
cell at 24 hpi (P = 0.022), from 79 to 30 copies/cell at 48 hpi
(P = 0.001), and from 245 to 123 copies/cell at 72 hpi (P = 0.001)
(Fig. 4C). Finally, miR-US33 transduction reduced the amounts of
infectious virus in the culture supernatants from 3.46103 to
1.96103 pfu/ml at 96 hpi (P = 0.0001) and from 8.66105 to
3.16105 pfu/ml at 144 hpi (P = 0.012) (Fig. 4D).
MiR-US33 repressed expression of its target HCMV US29
Most miRNAs contain short (2–8 nt) ‘seed’ regions that can
base pair with target mRNAs to form exactly matched 6–7 nt
regions of double-stranded RNA [36]. Sequence alignments
identified HCMV US29 as a predicted target for miR-US33-3p
[37–39] (Fig. 5A). A luciferase reporter assay was devised to
determine if this US29 sequence functions as a target for miR-
US33. The predicted US29 target sequences were inserted into the
39 untranslated region of a mRNA encoding luciferase that was
expressed from a plasmid by transient transfection. pCDH-miR-
US33 or the pCDH-copGFP was cotransfected with the lucifer-
ease-US29 reporter plasmid and a control plasmid expressing b-gal
into 293T/17 cells. Luciferase activities were normalized to b-gal
activities measured in the same cells 48 h post transfection. Cells
expressing miR-US33 had 2.6-fold lower luciferase activity
compared to those transduced with empty vector (P = 0.002)
(Fig. 5B).
To determine whether US29 transcripts are affected by miR-
US33 during HCMV infection, HELs transduced with miR-
US33-expressing or vector control lentiviruses were infected with
HCMV (MOI= 0.01) and US29mRNA levels were quantitated by
qRT-PCR. US29 transcript levels were reduced by nearly half at
24 hpi (P = 0.002), confirming that miR-US33 can down-regulate
US29 mRNA in the context of HCMV infection (Fig. 5C). The
inhibition of US29 transcription became insignificant with the
progress of HCMV infection at 48 and 72 hpi. The inhibition
effect was probably masked by other viral proteins after the viral
replication initiation.
Discussion
Following primary infection HCMV establishes a latent/
persistent infection characterized by latency with periodic or
sporadic reactivation [40,41]. Primary infection and reactivation
result in serious, sometimes life-threatening complications in
individuals with impaired or immature immune systems, including
AIDS patients, transplant recipients, and fetuses infected in utero
[1,42–44].
During latency, expression of viral genes associated with lytic
replication is repressed. In HCMV, robust expression of IE1/2
proteins through active transcription from the major immediate
early promoter (MIEP) is crucial for driving cells forward in the
lytic replication cycle. Conversely, repression of IE1/2 expression
may promote establishment of latency in some cell types or
abortive infection in others. During natural latency the MIEP is
associated with markers of repressed chromatin and repressive
chromatinization occurs rapidly after experimental infection in cell
Figure 3. Expression comparison of representatives of miRNAs in THP-1 and d-THP-1 cells. The THP-1 and d-THP-1 cells were infected
with Towne at an MOI of 10, and cells were harvest at the indicated times post infection, respectively. Expression kinetics for four HCMV miRNAs (miR-
112 and miR-70-3p, miR-22A-5p, and miR-US33-3p) is shown side-by-side to compare expression patterns in THP-1 vs. d-THP-1(data are from
experiments described in Fig S1 and S2). The different fold change of time points were shown above, **P,0.01, *P,0.05.
doi:10.1371/journal.pone.0088531.g003
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culture models of latency [17,45–47]. Repressive chromatinization
is thought to occur by default upon delivery of the viral genome to
the nucleus; to enter lytic replication the viral tegument protein
pp71 must traffic to the nucleus where it acts to de-repress IE
transcription by inducing degradation of Daxx [48]. In cell culture
latency models, including THP-1s, de-repression fails because
pp71 does not enter the nucleus [49]. Thus, in the early hours post
infection the decision to enter a latent vs. lytic program depends
on interplay of cellular and viral factors to activate or repress the
MIEP. Additional mechanisms may influence or fine-tune the
decision making process. Once committed to a lytic or latent
program, complex mechanisms govern progression through the
lytic cycle, and presumably, additionally complex but little
understood mechanisms are needed to establish and maintain
the latent state and to drive re-entry into the lytic pathway upon
reactivation.
The immunologically inert nature of miRNAs makes viral
miRNA-mediated mechanisms for governing latency intellectually
attractive, and indeed, control of viral and host genes by viral
miRNAs during latency has been demonstrated for several viruses
in the alpha- and gamma-herpesvirus subfamilies (reviewed in [4]).
Thus far HCMV miRNAs have only been characterized during
lytic infection. While such studies have identified HCMV miRNAs
that mediate immune evasion, modulate cell cycle regulation, and
either up- or down-modulate lytic replication (recently reviewed in
[8,50]), expression of HCMV miRNAs has not as yet been
evaluated during latency either in vivo or in experimental cell
culture latency models.
In the present work expression and kinetics of 16 mature
HCMV miRNAs were examined during lytic replication in
fibroblasts (Fig. 1) and directly compared during quiescent
infection of undifferentiated THP-1 monocytes (Fig. 2 and Fig.
S1) and semi-permissive lytic replication in THP-1-derived
macrophages (d-THP-1, Fig. 3 and Fig. S2). While infection in
THP-1 is not considered a true model of HCMV latency by some
investigators because reactivation to produce infectious progeny
Figure 4. Impact of ectopic expression of miRNAs on HCMV replication. (A) HCMV miRNA levels were quantitated by stem-loop RT-PCR in
HEL cells 48 h after transduction with empty vector lentivirus (control) or with lentiviruses engineered to express miR-UL22A, miR-UL70, miR-US33, or
48 hpi of HELs with HCMV strain Towne (MOI = 5). Results represent fold-differences for each miRNA relative to control. (B) Levels of IE1, IE2, UL44, or
gB were determined by western blotting. Actin serves as a loading control. Control lentivirus (2) or lentiviruses expressing according miRNAs (+) are
indicated. (C) HELs were infected with HCMV strain Towne at an MOI of 0.01 48 h after transduction with control lentivirus or lentivirus expressing
miR-US33. At the times indicated post infection HCMV genome copy numbers were determined by qPCR. (D) HELs were infected with HCMV strain
Towne at an MOI of 0.01 48 h after transduction with control lentivirus or lentivirus expressing miR-US33 Infectious virus titers in supernatants at 96
and 144 hpi were determined. Inhibition efficiencies are % changes in virus titers in medium from HCMV-infected miR-US33-transduced cells vs.
control-transduced cells. **P,0.01, *P,0.05.
doi:10.1371/journal.pone.0088531.g004
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has not be clearly established. THP-1 infection has been used to
model maintenance of viral genomes in a transcriptional quiescent
state [17–21,49,51–54].
Fifteen of the 16 HCMV-encoded miRNAs were highly
expressed during lytic infection in HELs, consistent with previous
findings that HCMVmiRNAs are responsible for up to 20% of the
total miRNAs in infected cells [55]. While kinetic class was not
determined for miRNAs using inhibitors of protein or viral DNA
synthesis, the 11 HCMV miRNAs designated as group 1 were
induced to significant levels by 6 hpi and reached high peak levels
at 48 hpi, suggesting possible roles in modulating lytic replication
during immediate early, early, or late phases of replication.
Functions for several of these miRNAs have been reported.
HCMV miR-UL112-1 down-regulates MICB to escape NK cell
recognition and targets viral proteins IE1 and UL114 [13,56],
while miR-US25-1 and miR-US25-2 target cell cycle regulators
such as cyclin E2 [15,39].
The less efficient lytic replication that occurs in d-THP-1 cells
exhibited similarly robust induction of six HCMV miRNAs,
suggesting a common core of miRNAs associated with lytic
replication in both cell types. Consistent with a general delay in
lytic gene expression [26], HCMV miRNA expression in d-THP-1
cells was delayed approximately 24 h relative to HEL infection
(Fig. S2). However, two miRNAs that were highly expressed
during lytic infection in HELs (miR-UL36-3p and miR-US5-2)
were not detected at all in d-THP-1 cells, while seven, including
miR-UL36-5p and miR-US5-1, were significantly less induced
compared to HELs (Fig. S2, Fig. 1). It is tempting to speculate that
low or absent expression of some of these miRNAs contributes to
inefficiency of replication in d-THP-1 cells. Consistent with this
hypothesis, two recent reports suggest roles for miR-UL36 and
miR-US5-2 in promoting efficient lytic replication. In one study
miR-UL36 was shown to down regulate expression of the latency-
associated protein UL138 and ectopic expression of miR-UL36
enhanced HCMV DNA synthesis during the early stages of
replication in fibroblasts [57]. The second study confirmed that
miR-US5-1 and -2 target and down-regulate US7, and found that
viral mutants lacking miR-US5-1, miR-US5-2, or both have a
modest growth impairment in fibroblasts [58]. Finally, one
miRNA (miR-UL70-3p) was strongly induced in d-THP-1 cells
but not in HELs, suggesting a possible role during macrophage
infection but not in fibroblasts.
HCMV miRNA expression during quiescent infection of THP-
1 cells was characterized by overall low level induction of all 16
miRNAs studied (Fig. S1). It therefore appears that miRNAs are
subject to the same transcriptional repression that blocks IE
expression in these cells. That none of the 16 miRNAs examined
were robustly expressed within the first 24–48 hpi suggests that a
role for these miRNAs in early suppression of the lytic program is
unlikely. However, three miRNAs (miR-UL112, -UL70-3p, -US5-
1) showed modest increases of 3- to 4-fold at 72 hpi, and thus
could potentially function in maintenance of the quiescent state.
That miR-US5-1 and miR-US5-2 target regulators of cell cycle
during lytic replication may suggest a similar role during latency
[15,39].
Three previously uncharacterized miRNAs were tested for their
ability to impact lytic replication when expressed ectopically
(Fig. 4). Ectopic expression of miR-UL22A and miR-UL70 had no
detectable effects on HCMV replication following infection at low
or high MOI. However, ectopic expression was lower compared
with levels induced by viral infection and may have been
insufficient to induce a phenotype. Following low (0.01) MOI
infection ectopically expressed miR-US33 impaired expression of
IE, E, and late gene products, diminished accumulation of
Figure 5. Down-regulation of HCMV US29 by miR-US33. (A) Complementarity of miR-US33 with its putative target sequence in US29; the miR-
US33 ‘‘seed’’ sequence is underlined. (B) US29 sequences are a target of miR-US33. A plasmid expressing luciferase from a transcript containing the
putative miR-US33 target sequence from US29 was co-transfected into 293 cells with a plasmid expressing miR-US33 or an empty vector control
plasmid. Each transfection also included a b-gal-expressing plasmid to normalize transfection efficiencies. Luciferase and b-gal activities were
measured 48 h post transfection and b-gal activities were used to normalize the luciferase activities. (C) Regulation of US29 mRNA by miR-US33
during HCMV infection. HELs were infected with HCMV strain Towne at an MOI of 0.01 48 h after transduction with control lentivirus or lentivirus
expressing miR-US33 and at the indicated hpi US29 mRNA levels were quantitated by RT-PCR. **P,0.01.
doi:10.1371/journal.pone.0088531.g005
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intracellular viral DNA, and reduced the yield of infectious
progeny (Fig. 4). While these effects were modest and only
observed at low MOI, it must again be considered that levels of
ectopically expressed miR-US33 were much lower than those
expressed during HCMV infection; thus, the impact of ectopic
expression would likely only be manifested in the first 24–48 hpi,
as by 48 hpi miR-US33 expressed from the HCMV genome
would likely overwhelm that expressed ectopically.
Pre-miR-US33 is encoded by sequences complementary to
US29 and US29 transcripts were therefore a potential miR-US33
target. The luciferase reporter assay confirmed the ability of miR-
US33 to target proteins expressed from transcripts containing
US29 sequences and ectopic expression of miR-US33 reduced the
level of viral US29 mRNA in the context of HCMV infection
(Fig. 5). While lack of a US29-specific antibody renders analysis of
US29 protein levels currently impractical, the available data
strongly suggest that US29 is a miR-US33 target. Based on growth
properties of deletion mutants, US29 has been classified as
‘‘dispensable’’ or ‘‘nonessential’’ for viral replication [59,60].
However, these results do not preclude the possibility that US29
may have modest effects in augmenting viral replication as these
studies considered mutants that replicated within 5-fold [60] or 10-
fold [59] of wild type to be unimpaired. Thus, the impaired growth
phenotype we observed in cells expressing ectopic miR-US33
could be a consequence of reduced US29 expression; however, the
possibility that miR-US33 impairs HCMV replication by targeting
other viral or cellular genes cannot presently be ruled out.
Regardless of the target, the evidence indicates that miR-US33
represses lytic replication and thus could facilitate the establish-
ment or maintenance of HCMV latency.
In summary, expression patterns for 16 HCMV miRNAs
differed significantly following infection of cell culture systems
representing permissive and semi-permissive lytic replication and
quiescent genome maintenance. These differences in miRNA
expression may imply diverse functional roles in different cellular
environments and different viral replication programs. An
additional HCMV miRNA (miR-US33) as found to suppress
HCMV lytic replication, adding to an emerging theme that a
significant subset of HCMV miRNAs function to down-modulate
lytic replication. The role(s) such miRNAs may play in latency
awaits further studies to characterize miRNA expression during
natural latency and to evaluate miRNA null mutants in cell culture
latency models.
Supporting Information
Figure S1 Expression kinetics of HCMVmiRNAs during
quiescent infection of THP-1 cells. Undifferentiated THP-1
monocytes were infected with HCMV strain Towne at an MOI of
10 and intracellular HCMV miRNAs were quantitated by stem-
loop RT-PCR at the indicated times post infection. Results
indicate fold-changes relative to levels measured at 3 hpi.
(TIF)
Figure S2 Expression kinetics of HCMVmiRNAs during
semi-permissive replication in d-THP-1 cells. THP-1
monocytes were differentiated into macrophages by culture for
24 h in medium containing PMA and hydrocortisone. Resulting
d-THP-1 cells were infected with HCMV strain Towne at an
MOI of 10 and intracellular HCMV miRNAs were quantitated by
stem-loop RT-PCR at the indicated times post infection. Results
indicate fold-changes relative to levels measured at 3 hpi.
(TIF)
Table S1 Comparison of Ct values of strongly induced
miRNAs in d-THP-1 vs. HEL.
(DOC)
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